What photobiomodulation is
Photobiomodulation uses selected red and near-infrared wavelengths to interact with cellular signalling—mitochondrial and redox pathways among them. Wavelength, exposure, device and tissue context all shape the response.
A distinct exposure
PBM differs from heat-based procedures and from ultraviolet exposure, and it is not interchangeable with natural daylight. A home device can complement time outdoors and studio care; it does not replace daylight, nor does it cancel the effects of an indoor, screen-lit life.
Evidence in proportion
Research spans laboratory work and human studies with particular devices and exposures. Melasma-specific PBM research includes a small seven-participant pilot—promising, and specific to its setting. We value PBM as supportive care within a broader plan.
Our approach at Kalamalka Glow
Red and near-infrared light is included with every studio treatment, and a suitable home device can extend that support between visits. Our Light page explores why this wavelength interests us so deeply.
References
- Hamblin: Anti-inflammatory mechanisms of PBM — review (2017)
- Barolet: Photobiomodulation in melasma — pilot study (2018)